UNF Graduate School’s Post

Learn more about the importance of using NGS testing to identify PIK3CA, AKT1, and PTEN alterations in HR+/HER2-advanced breast cancers. https://brnw.ch/21wJDyz #MedTwitter #NGSTesting

This is a good read talking about re-classifying certain cancers. https://lnkd.in/dAjFzryi

At #ASCO24 and #EHA2024 new data and real-world evidence using Adaptive’s clonoSEQ® for MRD assessment will be presented across a range of hematologic cancers. https://lnkd.in/gJuPg99B FDA-cleared to measure MRD in MM, CLL, & ALL; CLIA-validated in other lymphoid cancers. Review the FDA-cleared uses of clonoSEQ: https://rb.gy/8tju9y

Immune-reactive cluster (Cl-6) identified by gene-expression profiling may discriminate patients who will have a benefit from immunotherapy in rec/met head and neck squamous cel cancers. In multivariate analysis, Cl-6 survived as prognostic factor for OS and PFS over other clinical and biomolecular factors. May we start also in HNSCC to tell a tailored-treatment approach story?

Be a part of Cancer52's work to support the voice of rare & less common cancers by taking the Cancer52 survey. The findings will be used to improve services and outcomes for people with rare and less common cancers. *Rare & less common cancers are all cancers except for breast, bowel, lung and prostate. https://bit.ly/C52survey

A quick method using the SIMOA technology from Quanterix to isolate and detect EVs in breast cancers samples. If you are interested to find out more about SIMOA, please do reach out to us. #exsomes #biomarkers #breastcancer

#WorldCancerDay Did you know many common types of cancer can be prevented? Screening tests can find breast, cervical & colorectal cancers early, when they’re easiest to treat. What will you do to cut your risk? See what steps you can take: https://buff.ly/3XU9u1t

NavDx® is revolutionizing monitoring for HPV-related head and neck cancers. Watch as clinicians highlight how the innovative NavDx® blood test is changing HPV+ cancer recurrence detection. By streamlining surveillance, NavDx sets a new standard of care.   Discover how this technology can transform your practice: navdx.com/surveillance   #NavDx #CancerMonitoring #OncologyInnovation

We are highlighting the crucial role to support systems in the journey of those facing gynecological cancers. Here are 5 simple tips to consider when offering cancer support.

Diving into the numbers: Myeloma, a rare player in the cancer realm, claims just 1% of all cancers but holds a significant 13% stake among blood cancers. . . . . #MyelomaAwareness #RareCancers #BloodCancerStatistics #MyelomaFacts #CancerPrevalence #CancerStatistics #CancerAwareness #KnowTheNumbers #MyelomaAware #CancerStatistics #BloodCancerAwareness #CancerAwarenessMonth #RareCancerStatistics